Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
ReWalk Robotics Ltd RWLK CEO Larry Jasinski
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
ReWalk Robotics Ltd RWLK CEO Larry Jasinski on 2020 Results
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Unveiling Exploration Potential: Deflection Resources' Focus on Lachlan Fold Belt
00:10:00
Aboriginal Financial Institution Aims to Boost Economic Development in Northern Ontario
00:10:00
Cheong of China State Construction Sees Increasing Profits | WANG Xiaoguang, CEO, China State Construction International Holdings LtdC4S1:FRA
00:00:00
Pixium Vision - executive interview / Lloyd Diamond CEO, Pixium Vision
00:10:00
Setting Boundaries with Kyle Moore, CFP | Kyle Moore - FOUNDER, FINANCIAL PLANNER of Quarry Hill Advisors
00:10:00
The 1867 Project: Why Canada Should Be Cherished, Not Cancelled|Mark Milke,Professor,University of Canterbury
00:10:00
Unlocking Success with Our Technical Advisory Services Team | Rajiv Sharma, Group CEO, Coats Group PLCCOA:LSE
00:10:00
We aim to advance Catholic education in the Archdiocese of Philadelphia through innovative programs and projects initiated by Catholic schools, colleges, parishes, and religious and other Catholic-focused organizations. We provide financial support and as
00:10:00
Overview of Crawford Nickel Project's Market Potential and Sustainability Initiatives
00:10:00
Marc Halbfinger is the CEO of PCCW Global.
00:10:00
Clearing the Path for Healing and Reform in Policing America
00:10:00
GV originated as an independent venture capital firm for innovative founders|Andy Wheeler,General Partner,GV